Creations Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 10.00 K
as on 03-01-2025
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 03-01-2025
- Satisfied Charges ₹ 1.00 Cr
as on 03-01-2025
- Revenue -5.99%
(FY 2023)
- Profit 32.73%
(FY 2023)
- Ebitda 46.17%
(FY 2023)
- Net Worth 92.33%
(FY 2023)
- Total Assets -21.64%
(FY 2023)
About Creations Biosolutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K .
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nihar Eluri and Peddada Krishna serve as directors at the Company.
- CIN/LLPIN
U33200TG2018PTC123790
- Company No.
123790
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Creations Biosolutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nihar Eluri  | Whole-Time Director | 01-Jun-2023 | Current |
| Peddada Krishna | Director | 11-Sep-2020 | Current |
Financial Performance of Creations Biosolutions.
Creations Biosolutions Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.99% decrease. The company also saw a substantial improvement in profitability, with a 32.73% increase in profit. The company's net worth Soared by an impressive increase of 92.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Creations Biosolutions?
In 2023, Creations Biosolutions had a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹20.00 M
₹10.00 M
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2024 | Others | ₹2.00 Cr | Open |
| 05 Oct 2023 | State Bank Of India | ₹1.00 Cr | Satisfied |
How Many Employees Work at Creations Biosolutions?
Unlock and access historical data on people associated with Creations Biosolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Creations Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creations Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
